Biochemical characterization of a neuroserpin variant associated with hereditary dementia

American Journal of Pathology

Volumn 158, Issue 1, 2001, Pages 227-233

  Yazaki, M ^a   Liepnieks, J J ^a   Murrell, J R ^a   Takao, M ^a   Guenther, B ^a   Piccardo, P ^a   Farlow, M R ^a   Ghetti, B ^a   Benson, M D ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN PROTEIN; COMPLEMENTARY DNA; MUTANT PROTEIN; NEUROSERPIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARBOXY TERMINAL SEQUENCE; CASE REPORT; CELL INCLUSION; CLINICAL FEATURE; DEGENERATIVE DISEASE; DEMENTIA; DNA SEQUENCE; EXON; GENE MUTATION; GENETIC DISORDER; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN ISOLATION; SEQUENCE ANALYSIS;

EID: 0035139549     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63961-2     Document Type: Article

References (37)

1. Familial dementia caused by polymerization of mutant neuroserpin
2. Familial encephalopathy with neuroserpin inclusion bodies
3. Progressive dementia and epilepsy in a young adult: Unusual intraneuronal inclusions
4. Neuroserpin mutation S52R causes neuroserpin accumulation in neurons and is associated with progressive myoclonus epilepsy
5. A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy
6. A new test for detection of the His58 variant transthyretin allele in hereditary amyloidosis; creation of diagnostic restriction endonuclease recognition sites by PCR based mutagenesis
7. Human neuroserpin (PI12): cDNA cloning and chromosomal localization to 3q26
8. Protein aging hypothesis of Alzheimer disease
9. Identification of proteins secreted from axons of embryonic dorsal-root-ganglia neurons
10. Neuroserpin, an axonally secreted serine protease inhibitor
11. Neuroserpin is expressed in the pituitary and adrenal glands and induces the extension of neurite-like processes in AtT-20 cells
12. Expression of neuroserpin, an inhibitor of tissue plasminogen activator, in the developing and adult nervous system of the mouse
13. Studies in myoclonus epilepsy (Lafora body form). 1. Isolation and preliminary characterization of Lafora bodies in two cases
14. Studies of corpora amylacea. 1. Isolation and preliminary characterization by chemical and histochemical techniques. Arch Neurol
15. Studies in myoclonus epilepsy (Lafora body form). II. Polyglucosans in the systemic deposits of myoclonus epilepsy and in corpora amylacea
16. Myoclonus epilepsy with Lafora bodies: An ultrastructural and cytochemical study
17. Type IV glycogenosis (amylopeptinosis): Light and electron microscopic observations
18. A distinct form of adult polyglucosan body disease with massive involvement of central and peripheral neuronal processes and astrocytes: A report of four cases and a review of the occurrence of polyglucosan bodies in other conditions such as Lafora disease and normal aging
19. Corpora-amylacea and the family of polyglucosan disease
20. Structure of the mouse gene for the serine protease inhibitor neuroserpin (PI12)
21. Patterns of amino acids near signal-sequence cleavage sites
22. Neuroserpin, a brain-associated inhibitor of tissue plasminogen activator is localized primarily in neurons: Implications for the regulation of motor learning and neuronal survival
23. A 2.6 Å structure of a serpin polymer and implications for conformational disease
24. 1antitrypsin-deficient variant with mutation on a predicted conserved residue of the serpin backbone
25. malton
26. 1-antitrypsin PiZ
27. 1-antitrypsin variant (Pi-ZZ) associated with plasma activity deficiency
28. 1antitrypsin
29. Basis of the defect in α-1-antitrypsin deficiency
30. 1-antitrypsin deficiency
31. 1-antitrypsin deficiency
32. 1-antitrypsin isolated from human liver
33. Antithrombin-TRI (Ala382 to Thr) causing severe thromboembolic tendency undergoes the S-to-R transition and is associated with a plasma-inactive high-molecular-weight complex of aggregated antithrombin
34. 436⇒Thr) results in nonsubstrate-like behavior and in polymerization of the molecule
35. 1-antichymotrypsin deficiency in a heterozygote with liver and lung disease